Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-21-000091

Director sold 1,666 shares at an average $53.40 ($88,969)

From the SEC's structured data for this filing

Trades in this filing

SATO VICKI L · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-15 Sale : show line 1 in the form −230 $52.28 $12,024 130,935 D
2021-09-15 Sale : show line 2 in the form −676 $53.03 $35,848 130,259 D
2021-09-15 Sale : show line 3 in the form −620 $53.92 $33,430 129,639 D
2021-09-15 Sale : show line 4 in the form −140 $54.76 $7,666 129,499 D
Open-market sales · 1,666 sh · avg $53.40 · $88,969
Loading xslF345X03/wf-form4_163190905888608.xml…